Hi there,

The job of a journalist is to go to where the silence is — especially when those in power seek to silence voices that question or challenge power. That is what we do at Democracy Now! day in and day out, and we're able to do it because of financial support from people like you — people who trust and depend on our independent reporting. If you believe that freedom of speech and freedom of the press are essential to the functioning of a democratic society, please donate today. Thanks to a group of generous donors, all donations made today will be DOUBLED, which means your $15 gift is worth $30. Every dollar makes a difference. Thank you so much.

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Cipro: The Battle Over Bayer

Listen
Media Options
Listen

Today we’re going to look at the pharmaceutical giant Bayer, the maker of Cipro.

Bayer has long been a controversial company, beginning with its roots in the German company IG Farben, which workedhand in hand with the Nazis.

It has been sued by holocaust survivors for its role in forced labor, medical experiments and other crimes.

Its been sued by people with Hemophilia who contracted AIDS though tainted blood transfusions.

And it has been targeted by AIDS activists around the world for fighting against cheap AIDS drugs for poorercountries.

Cipro, the antibiotic that many say can help treat anthrax, is ten times as expensive as generic equivalents. That’swhat made Senator Charles Schumer call for the Bush Administration to break Bayer’s patent and produce genericequivalents of the drug.

The Bayer/Cipro controversy is a microcosm of the global conflict between public health and private profit, betweenthe needs of poor countries for cheap medicines and the desire of rich corporations to preserve their patents. Its aconflict that will come to head in a little over a week when the WTO hold’s a major ministerial meeting in Qatar,where poor countries will press the US to relax drug patents on life saving medicines.

Guests:

  • Sharon Anne Lynch, Health Gap global access project and ACT-UP New York.
  • James Love, Consumer Project on Technology.
  • Philipp Mimkes, Coordination Against BAYER-Dangers (CBG).

Related links:

Related Story

StoryMay 15, 2025“Trump’s Fake Refugees”: As U.S. Welcomes White South Africans, Trump Falsely Charges “Genocide”
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top